Forbes May 7, 2018
Geisinger doctors will soon start offering patients DNA sequencing as part of routine preventative care, the Danville, Pennsylvania-based health system’s president and CEO Dr. David Feinberg announced Sunday at the HLTH Conference in Las Vegas.
“We’re going to start doing it the same way we would talk to patients about getting a cholesterol check,” Feinberg said on a call with reporters Monday morning.
The new program is separate from Geisinger’s research partnership with Regeneron to sequence the DNA of patients enrolled in its MyCode study, which is continuing. That study has sequenced the DNA of thousands of patients so far, and about 3.5% have had findings doctors could do something about, Feinberg said. He thinks that number will go up.
...Today's Sponsors
Today's Sponsor